The main question is whether plasma concentrations of pro-inflammatory cytokines (IL-6, IL-1α, and TNF-α) can serve as predictive biomarkers for depression severity and whether these concentrations are modulated by gender among patients diagnosed with major depressive disorder (MDD). The gene discussed is TNF; the disease is major depressive disorder.